Filing Details
- Accession Number:
- 0001225208-17-013770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-11 12:19:58
- Reporting Period:
- 2017-08-10
- Filing Date:
- 2017-08-11
- Accepted Time:
- 2017-08-11 12:19:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1580664 | P John Groetelaars | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-10 | 12,482 | $136.37 | 31,445 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 8,608 | $97.69 | 40,053 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,597 | $84.58 | 42,650 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-10 | 23,687 | $318.73 | 18,963 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2017-08-10 | 12,482 | $0.00 | 12,482 | $136.37 |
| Common Stock | Option (Right to Buy) | Disposition | 2017-08-10 | 8,608 | $0.00 | 8,608 | $97.69 |
| Common Stock | Option (Right to Buy) | Disposition | 2017-08-10 | 2,597 | $0.00 | 2,597 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,161 | 2023-12-11 | No | 4 | M | Direct | |
| 0 | 2022-12-12 | No | 4 | M | Direct | |
| 0 | 2021-12-14 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for price increments ranging from $318.52 to $318.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 12,482 options vested and the remaining options vest on December 11, 2017.
- Options fully vested and are currently exercisable.
- Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Billionaire Hedge Funds
